Medifast INC Form 4 insider transactions

Director Elizabeth A. Geary reports acquisition of restricted stock units and disposal of common stock.

Director Michael A. Hoer reports acquisition of Medifast stock units through a director's deferred compensation plan.

Director Scott Schlackman reports acquisition of restricted stock units and disposal of common stock related to director fees.

Director Xian Ming acquired 10,149 restricted stock units of Medifast, Inc. related to director fees, vesting on June 20, 2025.

James P. Maloney, CFO of Medifast, Inc., reported the disposal of common stock to cover withholding tax obligations upon the vesting of restricted stock units.

Jonathan Barrett MacKenzie, VP of Finance & CAO at Medifast, Inc., reported disposing of shares to cover withholding tax obligations upon vesting of restricted stock units.

Daniel Chard, Chairman & CEO of Medifast, Inc., reports disposals of common stock to cover withholding tax obligations upon vesting of restricted stock units.

Medifast's Chief Financial Officer, James P. Maloney, reports the acquisition of 8,718 shares of common stock through a restricted stock unit grant.

Jonathan Barrett MacKenzie, VP, Finance & CAO of Medifast, Inc., acquired 2,565 shares of common stock through a restricted stock unit grant on March 13, 2024.

Medifast CEO Daniel Chard received 45,087 restricted stock units and reported beneficial ownership of Medifast shares, including those held in a family trust.

Director Scott Schlackman exercised stock options and sold shares of Medifast Inc. on March 8, 2024.